Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial

J Am Coll Cardiol. 2016 Feb 9;67(5):596-8. doi: 10.1016/j.jacc.2015.11.027.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / administration & dosage
  • Adenosine Monophosphate / adverse effects
  • Adenosine Monophosphate / analogs & derivatives*
  • Hemorrhage / chemically induced*
  • Humans
  • Myocardial Infarction / therapy*
  • Percutaneous Coronary Intervention / methods
  • Purinergic P2Y Receptor Antagonists / administration & dosage
  • Purinergic P2Y Receptor Antagonists / adverse effects
  • Randomized Controlled Trials as Topic
  • Research Design / statistics & numerical data

Substances

  • Purinergic P2Y Receptor Antagonists
  • Adenosine Monophosphate
  • cangrelor